Vaccine Renaissance Conference at the Institute for Immunology and Informatics

描述(由申请人提供)：首席研究员/项目主任(最后、第一、中间)：de Groot，Anne，S。摘要疫苗对全球健康产生了巨大的积极影响，挽救了数百万人的生命，预防了大流行。通过使用疫苗，小儿麻痹症、麻疹、腮腺炎、破伤风和天花等疾病几乎被根除。现在，随着全球大流行和生物恐怖主义的威胁，人们对疫苗的价值有了更多的认识。鉴于传染病在全球范围内的传播，新的致命病原体的出现，以及不断升级的生物恐怖主义威胁，我们建议发起一次疫苗复兴会议。罗德岛大学的免疫学和信息学研究所(I‘Cued)将为领先的疫苗研究人员和开发人员主办并组织一次为期三天的会议。该活动将于2011年10月、2012年和2013年在国际扶轮的普罗维登斯举行。I‘Cued的使命是通过将免疫组学的力量--信息学、基因组学和免疫学--应用于设计更好的疫苗和疗法来改善人类和动物的健康。I‘Cued由安妮·德·格鲁特医学博士用1300万美元的NIH U-19拨款创立，旨在利用最先进的生物信息学工具加快传染病和生物防御领域的疫苗发现。该研究所由德·格鲁特博士和丹尼斯·斯佩罗博士领导，他们都是经验丰富的研究人员和药物发现领域的领导者，都非常擅长组织科学活动。2011-2013年疫苗复兴大会的主要目标是为审查疫苗研究和开发的当前进展提供一个论坛，包括加速疫苗发现的新工具和新技术。会议的第二个目标是为全国疫苗研发界提供一个联网机会，从而为学术研究人员和疫苗行业领导者之间的合作创造重要机会。国家和地区疫苗行业和学术领袖将被邀请就其专业领域内疫苗的最新发展发表演讲。继2004年、2006年和2009年在罗德岛州普罗维登斯举行的三次非常成功的疫苗复兴大会之后，本次疫苗复兴大会将在I‘Cued举行。第四次会议计划于2010年10月举行。会议的全球号召力每年吸引了100多名与会者，不仅来自美国，而且来自世界各地。 公共卫生相关性：首席调查员/项目主任(最后、第一、中间)：德格鲁特、安妮、S·叙述性疫苗是拯救生命的唯一最重要的公共卫生工具。疫苗可延长生命周期和提高生活质量，并具有在疾病发生前预防疾病的优势。通过引进和使用疫苗，许多疾病已被根除或几乎被根除。然而，还有一些疾病尚未被攻克，疫苗设计的时机仍然成熟--艾滋病毒、丙型肝炎、结核病和疟疾等等。鉴于传染病的全球传播、传染病的重新出现、被忽视的热带病的持续存在以及生物恐怖主义威胁的不断升级，疫苗研究人员聚集在一起讨论他们的最新研究是很重要的。为此，罗德岛大学的免疫学和信息学研究所提议为领先的疫苗研究人员和生产商举办为期三天的会议。这次会议将强调学术研究人员与美国和世界各地以疫苗为导向的生物技术公司的代表之间的联系。本次会议“免疫学和信息学研究所的疫苗复兴会议”将于2011年10月至2013年10月在罗德岛州的普罗维登斯举行。

DESCRIPTION (provided by applicant): Principal Investigator/Program Director (Last, first, middle): De Groot, Anne, S. Abstract Vaccines have had an enormous positive impact on global health saving literally millions of lives and preventing pandemics. Diseases such as polio, measles, mumps, tetanus and smallpox have nearly been eradicated by the use of vaccines. Now with the threat of global pandemics and bioterrorism there is an increased awareness of the value of vaccines. Given the global spread of infectious disease, the emergence of virulent new pathogens and the escalating threat of bio-terrorism, we propose to initiate a Vaccine Renaissance Conference. The Institute of Immunology and Informatics (I'Cubed) at the University of Rhode Island will host and organize a three-day conference for leading vaccine researchers and developers. This event will take place in October 2011, 2012, and 2013 in Providence, RI. The mission of the I'Cubed is to improve human and animal health by applying the power of immunomics --informatics, genomics and immunology -- to the design of better vaccines and therapeutics. The I'Cubed was founded by Annie De Groot, M.D. with a 13M dollar NIH U-19 grant to accelerate vaccine discovery in the areas of infectious diseases and bio-defense using state-of-the-art bioinformatics tools. The Institute is led by Dr. De Groot and Dr. Denice Spero, both highly experienced researchers and leaders in the field of drug discovery and both highly skilled at organizing scientific events. The primary objective of the 2011-2013 Vaccine Renaissance Conference is to provide a forum for the review of current progress in the research and development of vaccines, including new tools and techniques for accelerating vaccine discovery. The second objective of the meeting is to provide a networking opportunity for the vaccine R & D community nationwide, therefore creating important opportunities for collaborations between academic researchers and vaccine industry leaders. National and regional vaccine industry and academic leaders will be invited to speak about recent vaccine developments in their area of expertise. This Vaccine Renaissance Conference at the I'Cubed will follow three highly successful Vaccine Renaissance conferences which took place in 2004, 2006 and 2009 in Providence, Rhode Island. A fourth Conference is planned for October 2010. The global appeal of the Conference attracted more than 100 participants each year not only from the United States, but also from around the world. PUBLIC HEALTH RELEVANCE: Principal Investigator/Program Director (Last, first, middle): De Groot, Anne, S. Narrative Vaccines are the single most important public health tool in saving lives. Vaccines improve the duration and quality of life and have the advantage of preventing diseases before they occur. Many diseases have been eradicated or nearly eradicated by the introduction and use of vaccines. However, there are diseases that have yet to be conquered and remain ripe for vaccine design- HIV, HCV, TB and Malaria to name a few. Given the global spread of infectious disease, the re-emergence of infectious diseases, the persistence of neglected tropical diseases, and the escalating threat of bio-terrorism, it is important for vaccine researchers to gather to discuss their latest research. To that end, the Institute for Immunology and Informatics at the University of Rhode Island proposes a three-day conference for leading vaccine researchers and producers. The conference will emphasize networking between academic researchers and representatives from vaccine-oriented biotechnology companies across the US and worldwide. This conference, "Vaccine Renaissance Conference at the Institute for Immunology and Informatics" will take place October 2011-2013 in Providence, Rhode Island.